Linagliptin D4 | CAS 2140263-92-7 - Request Quote
Linagliptin D4
| SZ CAT No: | SZ-L024D03 |
| CAS No | 2140263-92-7 |
| Mol.F. | C25H24D4N8O2 |
| Mol.Wt. | 476.6 |
| Inv. Status | Under Synthesis |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Linagliptin D4 is chemically (R)-8-(3-Aminopiperidin-1-yl-2,2,6,6-d4)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione. Linagliptin D4 is supplied with detailed characterization data compliant with regulatory guideline. Linagliptin D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linagliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2140263-92-7
Purchase 2140263-92-7
Order 2140263-92-7
Enquire 2140263-92-7
price of 2140263-92-7
2140263-92-7 Supplier
2140263-92-7 Manufacturer
2140263-92-7 Exporter
buy high quality Linagliptin D4
Purchase Linagliptin D4
Linagliptin D4 suppliers
Linagliptin D4 manufacturers
Linagliptin D4 price
Order Linagliptin D4
Enquire Linagliptin D4
Linagliptin D4 cost
Linagliptin D4 Supplier
Linagliptin D4 Distributor
Linagliptin D4 for Method Validation
Linagliptin Reference Standard
Linagliptin D4 for ANDA Filing
Linagliptin D4 for Forced Degradation Studies
Linagliptin D4 Identification Standards
Linagliptin D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.